Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients

O. M.Zack Howard, Moshe Talpaz, Hagop Kantarjian, David Seong, Andrzej Wedrychowski, Nikolaos Paslidis, Jeane Hester, Anne Cork, James Turpin, Gabriel Lopez-Berestein, Jose Trujillo, Jordan Gutterman, Emil Freireich, Albert Deisseroth

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Cytoplasmic protein extracts from chronic myelogenous leukemia (CML) cells contained an activity that altered the electrophoretic mobility of complexes formed between nuclear proteins and the transcriptional enhancers of interferon (IFN)-inducible genes. Exposure of CML cells to IFN-α diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes. The presence of clinical responsiveness to IFN-α correlated with the sensitivity to the IFN-induced change in the electrophoretic mobility of nuclear protein-DNA complexes. These data suggest that the action of IFN-α in CML may be linked to a pathway that can result in posttranslational modification of nuclear proteins.

Original languageEnglish (US)
Pages (from-to)1117-1130
Number of pages14
JournalBlood
Volume76
Issue number6
StatePublished - Sep 15 1990

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Interferon affects nuclear proteins in cells of clinically sensitive chronic myelogenous leukemia patients'. Together they form a unique fingerprint.

Cite this